IL1B and cancer: Overexpression of inflammatory factors promotes tumor development, while targeting inflammatory mediators, such as chemokines, cytokines (TNF-α and IL-1β), and key transcription factors (NF-κB and STAT3), reduces cancer growth and spread [19].